rhenium has been researched along with tamoxifen in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Jaouen, G; Le Bideau, F; Salmain, M; Top, S | 1 |
Geiger, WE; Hillard, EA; Jaouen, G; Top, S; Wu, K | 1 |
Alberto, R; Can, D; Carta, F; Fernandes, C; Innocenti, A; Mendes, F; Raposinho, P; Santos, I; Schmutz, P; Spingler, B; Supuran, CT | 1 |
Bhatia, A; Chhabra, A; Mittal, BR; Sharma, U; Shukla, J; Upadhyay, D; Vatsa, R | 1 |
4 other study(ies) available for rhenium and tamoxifen
Article | Year |
---|---|
New and efficient routes to biomolecules substituted with cyclopentadienyltricarbonylrhenium and -technetium derivatives.
Topics: Breast Neoplasms; Chemistry, Pharmaceutical; Cyclopentanes; Estrogens; Half-Life; Molecular Structure; Octreotide; Organometallic Compounds; Organotechnetium Compounds; Peptides; Proteins; Radioisotopes; Radiopharmaceuticals; Rhenium; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Tamoxifen; Technetium Tc 99m Sestamibi | 2001 |
Anodic properties of diarylethene derivatives having organometallic piano-stool tags.
Topics: Cations; Coordination Complexes; Electrochemical Techniques; Free Radicals; Manganese; Organometallic Compounds; Oxidation-Reduction; Rhenium; Tamoxifen | 2011 |
[(Cp-R)M(CO)3] (M=Re or 99mTc) Arylsulfonamide, arylsulfamide, and arylsulfamate conjugates for selective targeting of human carbonic anhydrase IX.
Topics: Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Proliferation; Coordination Complexes; HEK293 Cells; HeLa Cells; Humans; Hydrogen-Ion Concentration; Organotechnetium Compounds; Rhenium; Sulfonamides; Sulfonic Acids; Tamoxifen | 2012 |
Re-188-tricarbonyl tamoxifen as a theranostic radiopharmaceutical for estrogen receptor expressing breast cancers: radiolabeling, characterization and in-vitro cytotoxic assessment.
Topics: Humans; Radioisotopes; Radiopharmaceuticals; Rhenium; Tamoxifen | 2021 |